000834700 001__ 834700
000834700 005__ 20210129230724.0
000834700 0247_ $$2doi$$a10.1159/000477499
000834700 0247_ $$2ISSN$$a1015-9770
000834700 0247_ $$2ISSN$$a1421-9786
000834700 0247_ $$2pmid$$apmid:28605743
000834700 0247_ $$2WOS$$aWOS:000417567200004
000834700 037__ $$aFZJ-2017-04603
000834700 082__ $$a610
000834700 1001_ $$0P:(DE-HGF)0$$aMaus, Volker$$b0
000834700 245__ $$aIncomplete Large Vessel Occlusions in Mechanical Thrombectomy: An Independent Predictor of Favorable Outcome in Ischemic Stroke
000834700 260__ $$aBasel$$bKarger$$c2017
000834700 3367_ $$2DRIVER$$aarticle
000834700 3367_ $$2DataCite$$aOutput Types/Journal article
000834700 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1499775959_5739
000834700 3367_ $$2BibTeX$$aARTICLE
000834700 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000834700 3367_ $$00$$2EndNote$$aJournal Article
000834700 520__ $$aBackground and Purpose: Cerebral large vessel occlusion (LVO) in acute ischemic stroke (AIS) may be complete (CLVO) or incomplete (ILVO). The influence of ILVO on clinical outcome after mechanical thrombectomy (MT) remains unclear. We investigated primarily the clinical outcome in patients with AIS due to ILVO or CLVO. Methods: Five hundred three consecutive AIS patients with LVO treated with stent-retriever or direct aspiration-based MT between 2010 and 2016 were analyzed. The primary endpoint was favorable clinical outcome (modified Rankin Scale ≤2) at 90 days; secondary endpoints were periprocedural parameters. Results: Forty-nine patients (11.3%) with a median National Institutes of Health Stroke Scale (NIHSS) of 11 presented with ILVO and the remainder presented with CLVO and median NIHSS of 15 (p < 0.001). The median groin puncture-to-reperfusion time was 30 vs. 67 min, respectively (p < 0.001). Successful reperfusion was reached in 47 out of 49 ILVO (95.9%) vs. 298 out of 381 CLVO (78.2%; p < 0.005) with less retrieval maneuvers (1.7 ± 2.2 vs. 3.0 ± 2.5; p < 0.001). The favorable outcome at 90 days was 81% in patients with ILVO vs. 29.1% in CLVO (p < 0.001); respective all-cause mortality rates were 6.4 vs. 28.5% (p < 0.001). Periprocedural complications (6.9%) occurred exclusively in CLVO patients (p < 0.05). ILVO was associated with favorable clinical outcome independent of age and NIHSS in multivariate logistic regression both in the anterior (OR 3.6; 95% CI 1.8-6.9; p < 0.001) and posterior circulation (OR 3.5; 95% CI 1.8-6.9; p < 0.001). Conclusions: AIS due to ILVO is frequent and is associated with a nearly threefold higher chance of favorable clinical outcome at 90 days, independent of age and initial NIHSS compared to CLVO.
000834700 536__ $$0G:(DE-HGF)POF3-572$$a572 - (Dys-)function and Plasticity (POF3-572)$$cPOF3-572$$fPOF III$$x0
000834700 588__ $$aDataset connected to CrossRef
000834700 7001_ $$0P:(DE-HGF)0$$aYou, Seunghwa$$b1
000834700 7001_ $$0P:(DE-HGF)0$$aKalkan, Alev$$b2
000834700 7001_ $$0P:(DE-HGF)0$$aBorggrefe, Jan$$b3
000834700 7001_ $$0P:(DE-HGF)0$$aKabbasch, Christoph$$b4
000834700 7001_ $$0P:(DE-Juel1)131615$$aBarnikol, Utako Birgit$$b5
000834700 7001_ $$0P:(DE-HGF)0$$aStetefeld, Henning$$b6
000834700 7001_ $$0P:(DE-HGF)0$$aDohmen, Christian$$b7
000834700 7001_ $$0P:(DE-HGF)0$$aLiebig, Thomas$$b8
000834700 7001_ $$0P:(DE-Juel1)131720$$aFink, Gereon Rudolf$$b9$$ufzj
000834700 7001_ $$0P:(DE-HGF)0$$aMpotsaris, Anastasios$$b10
000834700 773__ $$0PERI:(DE-600)1482069-9$$a10.1159/000477499$$gp. 113 - 121$$n3-4$$p113 - 121$$tCerebrovascular diseases$$v44$$x1421-9786$$y2017
000834700 909CO $$ooai:juser.fz-juelich.de:834700$$pVDB
000834700 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131720$$aForschungszentrum Jülich$$b9$$kFZJ
000834700 9131_ $$0G:(DE-HGF)POF3-572$$1G:(DE-HGF)POF3-570$$2G:(DE-HGF)POF3-500$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bKey Technologies$$lDecoding the Human Brain$$v(Dys-)function and Plasticity$$x0
000834700 9141_ $$y2017
000834700 915__ $$0StatID:(DE-HGF)0400$$2StatID$$aAllianz-Lizenz / DFG
000834700 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz
000834700 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bCEREBROVASC DIS : 2015
000834700 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000834700 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000834700 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000834700 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search
000834700 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC
000834700 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bThomson Reuters Master Journal List
000834700 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000834700 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000834700 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000834700 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine
000834700 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences
000834700 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5
000834700 920__ $$lyes
000834700 9201_ $$0I:(DE-Juel1)INM-3-20090406$$kINM-3$$lKognitive Neurowissenschaften$$x0
000834700 980__ $$ajournal
000834700 980__ $$aVDB
000834700 980__ $$aI:(DE-Juel1)INM-3-20090406
000834700 980__ $$aUNRESTRICTED